Jim has more than 25 years of experience in the biopharmaceutical industry, in both small biotechnology and large pharmaceutical companies, specializing in early stage research, product development, cGMP manufacturing, technology transfer and the management of intellectual property. He has led the development of drug products from conception through process development and scale-up to manufacturing, and has extensive business development experience with large pharmaceutical and biotechnology companies. Prior to PhaseBio, Jim was Vice President, Technology Development at BioRexis Pharmaceutical and Director of Business Development at Aventis Behring. Jim invented albumin fusion proteins while at Delta Biotechnology in the United Kingdom, where he was head of research and development. Jim received a BSc in applied biology from the University of Wales and a PhD in fungal molecular genetics from the University of Bristol.